Approval · Notice of Compliance 5698 · 1994
HALOPERIDOL LA INJECTION: Notice of Compliance 5698
Issued September 21, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5698
- Date
- September 21, 1994
- Company
- Sabex Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antipsychotic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALOPERIDOL LA INJECTION | 02130297 | Cancelled Post Market |
| HALOPERIDOL LA INJECTION | 02130300 | Marketed |
Medicinal ingredients
- HALOPERIDOL DECANOATE 50 MG per ML
- HALOPERIDOL DECANOATE 100 MG per ML